Leiming Xia

492 total citations
32 papers, 307 citations indexed

About

Leiming Xia is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Leiming Xia has authored 32 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Immunology. Recurrent topics in Leiming Xia's work include CAR-T cell therapy research (6 papers), Computational Drug Discovery Methods (5 papers) and Protein Structure and Dynamics (4 papers). Leiming Xia is often cited by papers focused on CAR-T cell therapy research (6 papers), Computational Drug Discovery Methods (5 papers) and Protein Structure and Dynamics (4 papers). Leiming Xia collaborates with scholars based in China and United States. Leiming Xia's co-authors include Zhen Li, Yangyi Bao, Qingsheng Li, Lei Xu, Lei Xu, Qiao Li, Fan Yang, Kan Chen, Ximing Xu and Qibin Song and has published in prestigious journals such as Blood, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Leiming Xia

32 papers receiving 300 citations

Peers

Leiming Xia
Manish Thakur India
Liv Johannessen United States
Kwee Hyun Suh South Korea
Stacey Skala United States
Rachael Brake United States
Cath Eberlein United Kingdom
Shahin Assefnia United States
Efrat Flashner-Abramson Israel
Donna-Michelle Smith United Kingdom
Hannah Linden United States
Manish Thakur India
Leiming Xia
Citations per year, relative to Leiming Xia Leiming Xia (= 1×) peers Manish Thakur

Countries citing papers authored by Leiming Xia

Since Specialization
Citations

This map shows the geographic impact of Leiming Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leiming Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leiming Xia more than expected).

Fields of papers citing papers by Leiming Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leiming Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leiming Xia. The network helps show where Leiming Xia may publish in the future.

Co-authorship network of co-authors of Leiming Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Leiming Xia. A scholar is included among the top collaborators of Leiming Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leiming Xia. Leiming Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Junqing, Yingying Chen, Dongdong Ji, et al.. (2025). Meta-analysis on the effectiveness and safety of venetoclax-based combination therapy with hypomethylation in acute myeloid leukemia. European journal of medical research. 30(1). 330–330. 2 indexed citations
3.
4.
5.
Wang, Yi, Zhixue Zhang, Leiming Xia, et al.. (2024). SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma. BMC Medical Genomics. 17(1). 105–105. 5 indexed citations
6.
Xu, Lei, et al.. (2023). SRR-DDI: A drug–drug interaction prediction model with substructure refined representation learning based on self-attention mechanism. Knowledge-Based Systems. 285. 111337–111337. 19 indexed citations
7.
Bao, Xunxia, et al.. (2023). Pan-cancer analysis reveals the potential of hyaluronate synthase as therapeutic targets in human tumors. Heliyon. 9(8). e19112–e19112. 8 indexed citations
8.
Xia, Leiming, et al.. (2023). Drug-target binding affinity prediction using message passing neural network and self supervised learning. BMC Genomics. 24(1). 557–557. 21 indexed citations
9.
Xia, Leiming, et al.. (2023). SubMDTA: drug target affinity prediction based on substructure extraction and multi-scale features. BMC Bioinformatics. 24(1). 334–334. 23 indexed citations
10.
Xu, Lei, et al.. (2023). Molecular Property Prediction by Combining LSTM and GAT. Biomolecules. 13(3). 503–503. 24 indexed citations
11.
Hong, Jian, Leiming Xia, Xiaodong Yuan, et al.. (2022). TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes. Frontiers in Oncology. 12. 879471–879471. 3 indexed citations
12.
Xia, Leiming, Lu Wen, You Qin, et al.. (2021). HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells. Cell chemical biology. 28(5). 610–624.e5. 10 indexed citations
13.
Zhao, Shuai, Linlin Han, Shiqian Huang, et al.. (2021). Electroencephalogram Signatures of Agitation Induced by Sevoflurane and Its Association With Genetic Polymorphisms. Frontiers in Medicine. 8. 678185–678185. 3 indexed citations
14.
Xia, Leiming, Fan Yang, Suzhi Li, et al.. (2021). SHP2 inhibition enhances the anticancer effect of Osimertinib in EGFR T790M mutant lung adenocarcinoma by blocking CXCL8 loop mediated stemness. Cancer Cell International. 21(1). 337–337. 11 indexed citations
15.
Peng, Chun‐Wei, et al.. (2019). miR-100-3p inhibits cell proliferation and induces apoptosis in human gastric cancer through targeting to BMPR2. Cancer Cell International. 19(1). 354–354. 25 indexed citations
16.
Wu, Xi, et al.. (2019). Intra-operative cell salvage for cesarean delivery: a retrospective study using propensity score matched analysis. Chinese Medical Journal. 133(2). 183–189. 1 indexed citations
17.
Li, Qiao, Yi Wang, Ming Lin, et al.. (2019). Abstract A014: Phase I clinical trial with PD-1/MUC1 CAR-pNK92 immunotherapy. Cancer Immunology Research. 7(2_Supplement). A014–A014. 17 indexed citations
18.
Yang, Xia, Huimin Tao, Yangyang Hu, et al.. (2016). IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways. Oncotarget. 7(37). 60461–60474. 28 indexed citations
19.
Li, Qingsheng, Linjie Zhang, Ruixiang Xia, et al.. (2015). Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatment. Medical Principles and Practice. 24(5). 458–464. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manish Thakur Breakdown of academic impact, for papers by Liv Johannessen Breakdown of academic impact, for papers by Kwee Hyun Suh Breakdown of academic impact, for papers by Stacey Skala Breakdown of academic impact, for papers by Rachael Brake Breakdown of academic impact, for papers by Cath Eberlein Breakdown of academic impact, for papers by Shahin Assefnia Breakdown of academic impact, for papers by Efrat Flashner-Abramson Breakdown of academic impact, for papers by Donna-Michelle Smith Breakdown of academic impact, for papers by Hannah Linden
Rankless by CCL
2026